Movement Disorders From the Use of Metoclopramide and Other Antiemetics in the Treatment of Migraine

被引：24

作者：

Wijemanne, Subhashie ^{[1
,2
]}

Jankovic, Joseph ^{[1
,2
,3
]}

Evans, Randolph W. ^{[3
]}

机构：

[1] Baylor Coll Med, Parkinsons Dis Ctr, Houston, TX 77030 USA

[2] Baylor Coll Med, Movement Disorders Clin, Houston, TX 77030 USA

[3] Baylor Coll Med, Dept Neurol, 7200 Cambridge St,Suite 9A, Houston, TX 77030 USA

来源：

HEADACHE | 2016年 / 56卷 / 01期

关键词：

migraine; acute dystonic reaction; tardive dyskinesia; akathisia; metoclopramide; prochlorperazine; promethazine; TARDIVE-DYSKINESIA; ANTICHOLINERGIC PROPHYLAXIS; RANDOMIZED-TRIAL; ED TREATMENT; PROCHLORPERAZINE; AKATHISIA; INFUSION; DIPHENHYDRAMINE; HEADACHE; EFFICACY;

D O I：

10.1111/head.12712

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

Nausea and vomiting are a frequent accompaniment of migraine and anti-nausea medications are frequently used in its management. The majority of anti-nausea medications that are used in migraine are dopamine receptor blocking agents and therefore have the potential to cause drug-induced movement disorders. This article explores the risk of such drug-induced movement disorders in migraineurs who were treated with these medications.

引用

页码：153 / 161

页数：9

共 68 条

[41] Valbenazine granted breakthrough drug status for treating tardive dyskinesia [J].

Mueller, Thomas .

EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2015, 24 (06) :737-742

[42] American Gastroenterological Association technical review on the diagnosis and treatment of gastroparesis [J].

Parkman, HP ;

Hasler, WL ;

Fisher, RS .

GASTROENTEROLOGY, 2004, 127 (05) :1592-+

[43] Rate of metoclopramide infusion affects the severity and incidence of akathisia [J].

Parlak, I ;

Atilla, R ;

Cicek, M ;

Parlak, M ;

Erdur, B ;

Guryay, M ;

Sever, M ;

Karaduman, S .

EMERGENCY MEDICINE JOURNAL, 2005, 22 (09) :621-624

[44] Intravenous administration of metoclopramide by 2 min bolus vs 15 min infusion: does it affect the improvement of headache while reducing the side effects? [J].

Parlak, Ismet ;

Erdur, Bulent ;

Parlak, Mine ;

Ergin, Ahmet ;

Turkcuer, Ibrahim ;

Tomruk, Onder ;

Ayrik, Cuneyt ;

Ergin, Nesrin .

POSTGRADUATE MEDICAL JOURNAL, 2007, 83 (984) :664-668

[45] Drug Insight: from disturbed motility to disordered movement - a review of the clinical benefits and medicolegal risks of metoclopramide [J].

Pasricha, PJ ;

Pehlivanov, N ;

Sugumar, A ;

Jankovic, J .

NATURE CLINICAL PRACTICE GASTROENTEROLOGY & HEPATOLOGY, 2006, 3 (03) :138-148

[46] Review article: metoclopramide and tardive dyskinesia [J].

Rao, A. S. ;

Camilleri, M. .

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2009, 31 (01) :11-19

[47] NEUROLEPTIC MALIGNANT SYNDROME ASSOCIATED WITH METOCLOPRAMIDE [J].

ROBINSON, MB ;

KENNETT, RP ;

HARDING, AE ;

LEGG, NJ .

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1985, 48 (12) :1304-1304

[48] EXTRAPYRAMIDAL SIDE-EFFECTS OF ANTIEMETICS PRESENTING AS PSYCHIATRIC-ILLNESS [J].

RODGERS, C .

GENERAL HOSPITAL PSYCHIATRY, 1992, 14 (03) :192-195

[49] APPLICATION OF METOCLOPRAMIDE SPECIFICITY IN MIGRAINE ATTACKS THERAPY [J].

SCHWARZBERG, MN .

HEADACHE, 1994, 34 (07) :439-441

[50] Loss of dopamine neuron terminals in antipsychotic-treated schizophrenia; relation to tardive dyskinesia [J].

Seeman, Philip ;

Tinazzi, Michele .

PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2013, 44 :178-183

← 1 2 3 4 5 6 7 →